A review of 16 pediatric patients examined and treated from 1987 to 1991 is presented. The purpose for this review was to examine the different initial clinical presentation in the younger age group versus the older child and to identify the factors impacting on the patients’ surgical outcome, including the patients’ age, clinical presentation and MRI findings. Patients’ ages ranged from 4 to 14 years. Ten were under 6 years of age. Seven males and 9 females were included. The diagnosis was confirmed by MRI in all patients and all were followed by clinical and MRI evaluations for at least 1 year postoperatively. The patients were grouped into three subgroups: (a) group IA patients with a Chiari I malformation, (b) group IB patients with a Chiari I malformation and syrinx, and (c) group IC patients with a Chiari I malformation and hydrocephalus with or without an associated syringomyelic cavity. A uniform surgical approach was used and tailored to the degree of anomalies seen on MRI. Patients with a Chiari IA and IB were treated by a suboccipital craniectomy, upper cervical laminectomy, arachnoidal retraction and duraplasty. Only 1 patient in group B required a syringosubarachnoid shunt initially. Patients with a Chiari IC malformation were treated by a ventriculoperitoneal shunt initially. The clinical presentation of younger children (less than 6 years old) appeared similar to older children (over 6 years of age) except for sleep apnea, which was limited to the younger age group. Patients with pronounced motor and sensory deficits had the worst prognosis for recovery. The patient’s age, duration of symptoms, type of Chiari I malformation and degree of downward tonsillar migration on MRI did not appear to have a negative impact on the final outcome.

Keywords:
Chiari I malformation, Syringomyelia, Scoliosis
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.